Toward improved effectiveness of bladder cancer immunotherapy

Pawel Kalinski; Jeffrey R Gingrich

doi:10.2217/imt.15.71

Toward improved effectiveness of bladder cancer immunotherapy

Immunotherapy. 2015;7(10):1039-42. doi: 10.2217/imt.15.71. Epub 2015 Oct 28.

Authors

Pawel Kalinski^{1

2}, Jeffrey R Gingrich^{2

3}

Affiliations

¹ Departments of Surgery, Immunology, Bioengineering, Microbiology and Infectious Diseases, University of Pittsburgh, PA 15260, USA.
² University of Pittsburgh Cancer Institute, Hillman Cancer Center, UPCI Research Pavilion Suite 1.46, 5117 Center Ave., Pittsburgh, PA 15213-1863, USA.
³ Department of Urology, University of Pittsburgh, Pittsburgh, PA 15260, USA.

PMID: 26507359
DOI: 10.2217/imt.15.71

No abstract available

Keywords: CTL; NK; bladder cancer; checkpoint blockade; chemokines; cytokines; dendritic cells; immunotherapy; interferons; microenvironment; natural killer; stroma; tumor.

Publication types

Editorial
Research Support, N.I.H., Extramural

MeSH terms

Humans
Immunotherapy* / methods
Immunotherapy* / trends
Urinary Bladder Neoplasms / immunology*
Urinary Bladder Neoplasms / therapy*

Grants and funding

P01CA132714/CA/NCI NIH HHS/United States